Sanchez-Esgua Gabriela, Reyes-Alvarez Juan, Perez-Santos Martin
Centro de Estudios del Desarrollo Económico y Social, Facultad de Economía, Benemérita Universidad Autónoma de Puebla, Puebla, CP 72570, México.
Dirección de Innovación y Transferencia de Conocimiento, Benemérita Universidad Autónoma de Puebla, Puebla, CP 72570, México.
Pharm Pat Anal. 2023 Jan;12(1):37-50. doi: 10.4155/ppa-2022-0048. Epub 2023 Feb 1.
: pharmaceutical patenting activity in developing countries, including Mexico, is unknown. : determine the activity of pharmaceutical patents by Mexican universities. : using 'university' as keyword and A61K, A61P and C07 as International Patent Classification codes, was searched to generate a perspective of pharmaceutical patent applications by Mexican universities. : 227 patents (186 granted patents + 41 not-granted patents) were claimed in the period 2000-2018. The leading university was the National Autonomous University of Mexico, followed by the Instituto Politecnico Nacional, Universidad Autonoma de Nuevo León and Universidad Autonoma de Puebla. The pharmaceutical concerns addressed were led by the fields of infectious, cancer and diabetes. : in Mexican universities, the licensing of pharmaceutical patents is still in its early stages.
包括墨西哥在内的发展中国家的制药专利活动尚不清楚。确定墨西哥大学的制药专利活动。以“大学”为关键词,并使用国际专利分类代码A61K、A61P和C07进行检索,以了解墨西哥大学的制药专利申请情况。2000年至2018年期间共申请了227项专利(186项已授权专利+41项未授权专利)。领先的大学是墨西哥国立自治大学,其次是国立理工学院、新莱昂自治大学和普埃布拉自治大学。所涉及的制药领域以传染病、癌症和糖尿病领域为主。在墨西哥大学,制药专利的许可仍处于早期阶段。